middle.news
Tissue Repair Launches Pivotal Phase 3 Trial for TR987® in Chronic Wound Care
3:17pm on Wednesday 29th of January, 2025 AEDT
•
Biotechnology
Read Story
Tissue Repair Launches Pivotal Phase 3 Trial for TR987® in Chronic Wound Care
3:17pm on Wednesday 29th of January, 2025 AEDT
Key Points
Phase 3 trial initiated with 600 participants across Australia and the US
TR987® showed significant healing improvements in Phase 2 trials
Trial involves major hospitals including Royal North Shore and Northwell Health
Chronic wounds affect millions globally, with high healthcare costs
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Tissue Repair (ASX:TRP)
OPEN ARTICLE